Status:
COMPLETED
Investigating Hereditary Cardiac Disease by Reprogramming Skin Cells to Heart Muscle
Lead Sponsor:
University of Dundee
Conditions:
Eletrophysiology of iPS-derived Cardiomyocytes
Eligibility:
All Genders
18+ years
Brief Summary
Hereditary cardiac arrhythmias (genetically caused disturbances of heart rhythm) are life threatening conditions affecting otherwise healthy young individuals. Due to the inaccessibility of heart tiss...
Eligibility Criteria
Inclusion
- Clinical features of Brugada Syndrome (ECG findings)
- mutation positive or mutation negative
- Idiopathic ventricular fibrillation
Exclusion
- not able to give informed consent
- Age less than 18 years
- clinical diagnosis ambiguous
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01865981
Start Date
June 1 2013
End Date
June 1 2017
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Dundee
Dundee, Angus, United Kingdom, DD1 9SY